We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Portable Nucleic Acid Extraction System Developed For POC Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2013
A portable, pressure driven, room temperature nucleic acid extraction and storage system for point of care (POC) molecular diagnostics has been developed. More...


A minimally instrumented sample preparation technology yields a purified and thermally stabilized nucleic acid sample that eliminates the cold chain without reducing sensitivity or an increase in downstream processing infrastructure.

Biomedical engineers at Boston University (MA, USA) have developed a whole blood compatible, enzyme-free, ambient temperature, low-pressure nucleic acid extraction process that enables the creation of a completely powerless nucleic acid sample preparation technology. This technology will allow, for example human immunodeficiency virus (HIV) viral load monitoring in low resource areas.

A novel hybrid alcohol precipitation and solid phase extraction process has been presented, utilizing glycogen carrier particles to increase the effective hydrodynamic radius of precipitated nucleic acids aggregates, and a thermally polymerized acrylate based solid phase as a weir for analyte capture. An air pressure driven mechanical system was developed to perform this process in a semiautomated fashion, in order to insulate the process from variations in operator technique. Together, they form the System for Nucleic Acid Purification (SNAP).

The portable system for centrifuge-free room temperature nucleic acid extraction from 70 μL of whole blood uses only thermally stable reagents compatible with storage and transport in low resource settings. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of simulated samples demonstrate a lower limit of detection of 1,000 copies per mL, with the ability to detect differences in viral load across four orders of magnitude.

The device weighs less than 1.36 kg and is capable of extracting HIV-1 viral ribonucleic acid (RNA) directly from virions in whole blood in less than 35 minutes. Samples are stabilized on detachable cartridges, which can be eluted either at the point of care, or transported to a centralized laboratory for further analysis. The study was published on May 13, 2013, in the journal Analytical Methods.

Related Links:

Boston University




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.